Atrial Fibrillation

HomeCirculationVol. 95, No. 3Atrial Fibrillation Free AccessResearch ArticleDownload EPUBAboutView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticleDownload EPUBAtrial FibrillationA Tachycardia-Induced Atrial Cardiomyopathy Douglas P. Zipes Douglas P. ZipesDouglas P. Zipes the Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, and the Roudebush Veterans Administration Medical Center, Indianapolis, Ind. Search for more papers by this author Originally published4 Feb 1997https://doi.org/10.1161/01.CIR.95.3.562Circulation. 1997;95:562–564Atrial fibrillation and ventricular tachyarrhythmias occurring in patients with structurally abnormal hearts are the most important arrhythmias in contemporary cardiology. They represent the most frequently encountered tachycardias, account for the most morbidity and mortality, and, despite much progress, remain therapeutic challenges. Virtually all other supraventricular arrhythmias and most monomorphic ventricular tachycardias in patients with structurally normal hearts can be cured by RFCA.Atrial fibrillation affects a larger population than ventricular tachyarrhythmias, with a prevalence of ≈0.5% in patients 50 to 59 years old, incrementing to 8.8% in patients in their 80s. Indeed, Framingham data indicate that the age-adjusted prevalence, particularly in men, has increased substantially over the last 30 years.1 Atrial fibrillation usually accompanies disorders such as rheumatic and coronary heart disease, heart failure, mitral valve prolapse, hypertension, cardiomyopathies, hyperthyroidism, and the postoperative state but can occur in the absence of any recognized abnormality (lone atrial fibrillation) in at least 10% of cases. Although it may not carry the inherent lethality of a ventricular tachyarrhythmia, it does have a mortality twice that of control subjects,1 and the palpitations, hemodynamic consequences, side effects of drugs, and, most importantly, brain involvement due to thromboembolic complications make atrial fibrillation a formidable problem. It is a frontier to be challenged, as clinicians wrestle with its three most important clinical issues: control of the ventricular rate, maintenance of sinus rhythm, and prevention of thromboembolism.Recently, we have begun to understand some of the electrophysiological issues surrounding atrial fibrillation, and in the context of this editorial, two aspects will be addressed because they translate into therapeutic advances. The first is what we have learned about the electrophysiological mechanisms responsible for the onset of atrial fibrillation, and the second is what we know about its maintenance. It is important to remember, however, that there are probably different types of atrial fibrillation, even though they can have similar ECG appearances, so that this new information may not necessarily apply to all forms of atrial fibrillation.The report by Jai¨s et al2 in this issue of Circulation, which represents a continuation of their initial observation published in the Journal of Cardiovascular Electrophysiology,3 sheds light on the first question. They have found that atrial fibrillation in nine patients from a cohort (number not specified) referred for treatment of resistant paroxysmal atrial fibrillation was not due to the multiple reentrant wavelet hypothesis of Moe but rather to a single, rapidly discharging focus, similar to a pacemaker or a generator, that created an ECG pattern of atrial fibrillation. Elimination of the focus by RFCA also eliminated the apparent fibrillation.This observation is important for two reasons. First, from an electrophysiological standpoint, it provides one mechanism to explain how atrial fibrillation can start. Second, it identifies a population of patients, the size of which has yet to be established, for whom RFCA can provide a cure. It is probable that in some of these patients, the atria remodel over a period of time (see below), owing to the frequent recurrence of fast atrial rates, and develop sustained atrial fibrillation, which is then much more difficult to cure with RFCA. Thus, it becomes important for the cardiologist to recognize the patient who may have a focal source of atrial fibrillation: relatively young of either sex; no structural heart disease; frequent episodes of intermittent atrial fibrillation, along with episodes of an atrial tachycardia; monomorphic premature atrial systoles that have contours similar to the P waves during tachycardia; and a rate of atrial tachycardia, which is often irregular, >400/min and creating the ECG pattern of atrial fibrillation.Electrophysiologically, the focal origin of the tachycardia in most patients created a centrifugal endocardial activation, moving away from the focus. Because of the marked irregularity of the focal discharge, Jai¨s et al2 postulated an abnormal automatic or triggered mechanism. While this may or may not be true, at the present time it is of secondary importance because RFCA was effective, regardless of the mechanism. The foci were located at sites where atrial tachycardias have been noted in other studies, ie, near the sinus node and venae ostia, the coronary sinus in the right atrium and pulmonary veins in the left. Importantly for the electrophysiologist, foci located near the ostia of the right pulmonary veins, because they are located behind the right atrium, can create a positive P wave in leads I, II, and III that appears to originate in the right atrium.No complications are mentioned from the RFCA, and one patient required a second ablation procedure. Follow-up at 10 months showed no recurrence of the atrial tachycardia or fibrillation. It is important to stress that application of extensive RFCA lesions in the left atrium, not so much to ablate focal atrial fibrillation but to replicate the principle of the maze surgical procedure (see below), is not without risk of potential thrombus formation and systemic embolization. After the RFCA procedure, patients received subcutaneous low-molecular-weight heparinate daily for an unspecified time. No mention is made of long-term aspirin or warfarin treatment.A second type of atrial fibrillation onset occurs in patients who have other forms of SVTs, specifically AVNRT and AVRT. Because elimination of the AVNRT or AVRT by RFCA also eliminates atrial fibrillation in the majority of these patients, a logical conclusion is that the SVT in some manner initiates the atrial fibrillation, an example of a tachycardia-induced tachycardia. The following hypothesis can explain the connection. During AVRT and AVNRT, atrial systole occurs simultaneously with or shortly after ventricular systole, and therefore the AV valves are closed or at least not fully open when the atria contract. This then increases atrial pressure and produces atrial stretch, which in turn prolongs atrial refractoriness, an example of excitation-contraction feedback.45 Recently, it was shown in dogs that acute atrial stretch in response to a volume load that increased atrial pressure occurred heterogeneously, with thin areas of the atria stretching more than thick areas. Refractoriness followed suit, also being prolonged heterogeneously, and this dispersion of excitability made the atria vulnerable to induction of fibrillation.6 Thus, an excitation-contraction feedback loop in the atria creating electrical heterogeneity may be a second, stretch-induced mechanism responsible for the onset of atrial fibrillation.Other mechanisms, including autonomic influences,7 are probably operative in some of the disease states noted above, but the two just mentioned generate interest if for no other reason than the atrial fibrillation with which they are associated is easily cured by RFCA.Advances in understanding electrophysiological mechanisms responsible for the maintenance of atrial fibrillation have brought with them the recognition that the arrhythmia causes a tachycardia-induced atrial cardiomyopathy that results in electrophysiological and anatomic remodeling of the atria. These changes in turn facilitate the induction and perpetuation of the arrhythmia.In most instances, atrial fibrillation is maintained by multiple wavelets of reentry. Recently, Wijffels et al8 showed that induction of atrial fibrillation by intermittent rapid atrial pacing in goats led to a shortening of atrial refractoriness with loss of rate adaptation and caused an increase in the rate, inducibility, and stability of the atrial fibrillation. These electrophysiological changes facilitated the generation of multiple reentrant wavelets and thus caused atrial fibrillation to beget atrial fibrillation. Morillo et al9 made similar observations in dogs subjected to sustained rapid atrial pacing and also showed that dogs developed biatrial enlargement, an increase in mitochondrial size and number with disruption of the sarcoplasmic reticulum, and that cryoablation of the posterior left atrium could eliminate the atrial fibrillation. Most recently, Elvan and Zipes10 confirmed the findings of Wijffels et al8 and found that rapid pacing–induced atrial fibrillation in dogs prolonged intra-atrial conduction time and also depressed sinus node function. This latter observation raises the possibility that the tachycardia-induced atrial myopathy also causes sinus node remodeling and may contribute to clinical presentations such as the bradycardia-tachycardia syndrome. Because the changes shown by these groups of investigators appear to be reversible, at least to a degree, the therapeutic corollary is naturally whether attempts to restore sinus rhythm are warranted under the premise that sinus rhythm begets sinus rhythm. These concepts are being tested.It is often difficult to maintain sinus rhythm, particularly when atrial fibrillation has been present for long durations and presumably the atria have undergone extensive remodeling. Drug therapy can reduce the number of recurrences of atrial fibrillation and lengthen the interval between episodes,1 but breakthrough arrhythmia does occur, and drug side effects often limit patient compliance. A recent study in dogs11 showed that the pericardial sac can be used as a drug dispenser to target a drug such as amiodarone at the heart and minimize systemic effects while still having an impact on atrial fibrillation.Nonpharmacological approaches to treating patients with atrial fibrillation are proliferating. Control of the ventricular rate is easily achieved with RFCA modification of AV conduction,12 and studies with an implantable atrial defibrillator are under way.13 At least three different surgical techniques have been used to eliminate atrial fibrillation, the most well known being the maze operation developed by Cox.14 This is based on the principle that if the amount of excitable atrial myocardium at any one time could be reduced by surgically creating lines of block that form an obligatory path of depolarization in the atria, the number of reentrant wavelets of fibrillation would also be reduced and atrial fibrillation could not be maintained. Once again the arrhythmia surgeon has pioneered a new approach to eliminate cardiac arrhythmias by altering structure to improve function, and once again the electrophysiologist is fast on his heels. RFCA, by replicating the principle of the maze operation by introducing linear lesions in the atria, has now been shown capable of eliminating atrial fibrillation in animals (Reference 15 and A. Elvan, MD, et al, unpublished data, 1996) and patients,1617 although the procedure must be regarded as investigative with many issues still to be worked out. Nevertheless, it offers the possibility of eradicating atrial fibrillation without surgery.Atrial RFCA also vagally denervates the atria, which may contribute to its effectiveness15 ; this may be true of the maze operation also. Complete and selective vagal denervation of the atria in dogs has now been accomplished and experimentally can prevent induction of atrial fibrillation.18 If this approach is effective clinically, it should be easily completed by thoracoscopy. Finally, combined therapies may be useful, eg, drug-delivery devices and/or atrial RFCA to lower atrial defibrillation thresholds and make shocks from the implantable atrial defibrillator more tolerable, biatrial pacing to prevent recurrences, and so forth.In summary, it is clear that atrial fibrillation no longer takes a back seat to other SVTs such as AVNRT and AVRT. In fact, as the potential pool of patients with these arrhythmias diminishes,19 RFCA of atrial fibrillation may become the mainstay of the clinical cardiac electrophysiologist. Considering the number of patients with this arrhythmia, clinical cardiac electrophysiologists should expect job security into the 21st century.Selected Abbreviations and AcronymsAVNRT=atrioventricular nodal reentrant tachycardiaAVRT=atrioventricular reentry tachycardiaRFCA=radiofrequency catheter ablationSVT=supraventricular tachycardiaThe opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.This study was supported in part by the Herman C. Krannert Fund and by grant HL-52323 from the National Heart, Lung, and Blood Institute of the National Institutes of Health.FootnotesCorrespondence to Douglas P. Zipes, MD, Krannert Institute of Cardiology, 1111 W 10th St, Indianapolis, IN 46202-4800. References 1 Prystowsky EN, Benson DW Jr, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG. Management of patients with atrial fibrillation: a statement for healthcare professionals from the Committee on Electrocardiography and Electrophysiology, American Heart Association. Circulation.1996; 93:1262-1277.CrossrefMedlineGoogle Scholar2 Jai¨s P, Hai¨ssaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation..1997; 95:572-576.CrossrefMedlineGoogle Scholar3 Haissaguerre M, Marcus FI, Fischer B, Clementy J. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. J Cardiovasc Electrophysiol.1994; 5:743-751.CrossrefMedlineGoogle Scholar4 Kaseda S, Zipes DP. Contraction-excitation feedback in the atria: a cause of changes in refractoriness. J Am Coll Cardiol.1988; 11:1327-1336.CrossrefMedlineGoogle Scholar5 Klein LS, Miles WM, Zipes DP. Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure and refractory period: contraction-excitation feedback in human atrium. Circulation.1990; 82:60-68.CrossrefMedlineGoogle Scholar6 Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol.1996; 7:833-842.CrossrefMedlineGoogle Scholar7 Coumel P. Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol.1993; 4:338-355.CrossrefMedlineGoogle Scholar8 Wijffels MCEF, Kirchof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake, chronically instrumented goats. Circulation.1995; 92:1954-1968.CrossrefMedlineGoogle Scholar9 Morillo CA, Klein GJ, Jones DL, Guiradon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation.1995; 91:1588-1595.CrossrefMedlineGoogle Scholar10 Elvan A, Zipes DP. Pacing induced chronic atrial fibrillation impairs sinus node function in dogs. Circulation. In press.Google Scholar11 Ayers GM, Rho TH, Ben-David J, Besch HR Jr, Zipes DP. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol.1996; 7:713-721.CrossrefMedlineGoogle Scholar12 Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med.1994; 331:910-917.CrossrefMedlineGoogle Scholar13 Hillsley RE, Wharton JM. Implantable atrial defibrillators. J Cardiovasc Electrophysiol.1995; 6:634-648.CrossrefMedlineGoogle Scholar14 Cox JL, Jaquiss RD, Schuessler RB, Boineau JP. Modification of the maze procedure for atrial flutter and fibrillation, II: surgical technique of the maze II procedure. J Thorac Cardiovasc Surg.1995; 110:485-495.CrossrefMedlineGoogle Scholar15 Elvan A, Pride HP, Eble JN, Zipes DP. Radiofrequency catheter ablation of the atria reduces the inducibility and duration of atrial fibrillation in dogs. Circulation.1995; 91:2235-2244.CrossrefMedlineGoogle Scholar16 Swartz JF, Pellersels G, Silvers J, Patten L, Cervantes D. Catheter based curative approach to atrial fibrillation in humans. Circulation. 1994;90(suppl I):I-335. Abstract.Google Scholar17 Haissaguerre M. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol.1996; 7:1132-1144.CrossrefMedlineGoogle Scholar18 Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria, sinus and atrioventricular nodes: the third fat pad. Circulation. In press.Google Scholar19 Zipes DP. Arrhythmias on the endangered list. J Am Coll Cardiol.1993; 21:918-919.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Ezeani M, Noor A, Donnelly P, Niego B and Hagemeyer C (2022) Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes, Scientific Reports, 10.1038/s41598-022-08688-x, 12:1, Online publication date: 1-Dec-2022. Okazaki O, Higashino Y, Yokoya K, An Y, Tanizawa K, Imamura Y, Hayashi T, Akao M, Okumura K and Yamashita T (2022) Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis, American Heart Journal, 10.1016/j.ahj.2022.05.009, 250, (66-75), Online publication date: 1-Aug-2022. Cau R, Bassareo P, Suri J, Pontone G and Saba L (2022) The emerging role of atrial strain assessed by cardiac MRI in different cardiovascular settings: an up-to-date review, European Radiology, 10.1007/s00330-022-08598-6, 32:7, (4384-4394), Online publication date: 1-Jul-2022. Boriani G, Vitolo M and Imberti J (2022) Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000001316, 23:6, (359-362), Online publication date: 1-Jun-2022. Timsit S (2022) From cryptogenic to ESUS: Toward precision medicine?, Revue Neurologique, 10.1016/j.neurol.2022.01.016, Online publication date: 1-May-2022. Tan T, Korkmaz K, Akbulut I, Akin K, Yamanturk Y, Kurklu H, Kozluca V, Esenboga K and Dincer I (2022) Association between CHARGE-AF risk score and LA mechanics: LA reservoir strain can be a single parameter for predicting AF risk, Acta Cardiologica, 10.1080/00015385.2022.2059852, (1-9) Vogl B, Shaer A, Van Zyl M, Killu A, Alkhouli M and Hatoum H (2022) Effect of catheter ablation on the hemodynamics of the left atrium, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-022-01191-3 Stychynskyi O, Almiz P and Topchii A (2021) Atrial Cardiomyopathy: a Role in the Pathogenesis of Atrial Fibrillation and Influence on the Results of Its Treatment, Ukrainian Journal of Cardiovascular Surgery, 10.30702/ujcvs/21.4512/SA053-8589:4 (45), (85-89) Truong C, Nguyen B and Van Cong Tran T (2021) Prediction of risk factors for recurrence of atrial fibrillation in patients with arterial hypertension, The International Journal of Cardiovascular Imaging, 10.1007/s10554-021-02331-y, 37:12, (3413-3421), Online publication date: 1-Dec-2021. Kornej J, Magnani J, Preis S, Soliman E, Trinquart L, Ko D, Benjamin E and Lin H (2021) P-wave signal-averaged electrocardiography: Reference values, clinical correlates, and heritability in the Framingham Heart Study, Heart Rhythm, 10.1016/j.hrthm.2021.05.009, 18:9, (1500-1507), Online publication date: 1-Sep-2021. Wojdyła-Hordyńska A and Hordyński G (2020) Prevention of atrial fibrillation – non-modifiable and modifiable risk factors for AF, In a good rythm, 10.5604/01.3001.0014.2845, 2:55, (14-19), Online publication date: 30-Jun-2020. Darlington A and McCauley M (2020) Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2020.00011, 7 Shen M, Arora R and Jalife J (2019) Atrial Myopathy, JACC: Basic to Translational Science, 10.1016/j.jacbts.2019.05.005, 4:5, (640-654), Online publication date: 1-Sep-2019. Noubiap J, Bigna J, Agbor V, Mbanga C, Ndoadoumgue A, Nkeck J, Kamguia A, Nyaga U and Ntusi N (2019) Meta-analysis of Atrial Fibrillation in Patients With Various Cardiomyopathies, The American Journal of Cardiology, 10.1016/j.amjcard.2019.04.028, 124:2, (262-269), Online publication date: 1-Jul-2019. Agbor V, Aminde L, Tianyi F, Mbanga C, Petnga S, Ditah C and Noubiap J (2019) Atrial fibrillation among adults with heart failure in sub-Saharan Africa — prevalence, incidence and all-cause mortality: a systematic review and meta-analysis protocol, BMJ Open, 10.1136/bmjopen-2018-022320, 9:2, (e022320), Online publication date: 1-Feb-2019. Shukla M, Mohan V and Mohan J (2019) Arrhythmogenic isolated left atrial cardiomyopathy, Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging, 10.4103/jiae.jiae_14_19, 3:2, (85), . Beltrame M, Compagnucci P and Maolo A (2019) P-Waves Are the Main Clues for Correct ECG Interpretation New Concepts in ECG Interpretation, 10.1007/978-3-319-91677-4_1, (1-7), . Saito A, Amiya E, Hatano M, Hosoya Y, Maki H, Nitta D, Minatsuki S, Watanabe M and Komuro I (2017) Newly developed atrial fibrillation progresses to a more severe INTERMACS score in a patient with advanced heart failure due to dilated cardiomyopathy, Clinical Case Reports, 10.1002/ccr3.1247, 5:12, (2028-2033), Online publication date: 1-Dec-2017. Joy P, Gopinathannair R and Olshansky B (2017) Effect of Ablation for Atrial Fibrillation on Heart Failure Readmission Rates, The American Journal of Cardiology, 10.1016/j.amjcard.2017.07.057, 120:9, (1572-1577), Online publication date: 1-Nov-2017. Guichard J and Nattel S (2017) Atrial Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.06.033, 70:6, (756-765), Online publication date: 1-Aug-2017. Maeda S, Chik W, Liang J, Kelesidis I, Arroyo R, D’Souza B, Sadek M, Muser D, Squara F, Venugopal D, Santangeli P, Frankel D, Zado E, Marchlinski F and Callans D (2016) Recovery of renal dysfunction after catheter ablation of outflow tract ventricular arrhythmias in patients with ventricular premature depolarization-mediated cardiomyopathy, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-016-0190-x, 48:1, (43-50), Online publication date: 1-Jan-2017. Fung E, Järvelin M, Doshi R, Shinbane J, Carlson S, Grazette L, Chang P, Sangha R, Huikuri H and Peters N (2015) Electrocardiographic patch devices and contemporary wireless cardiac monitoring, Frontiers in Physiology, 10.3389/fphys.2015.00149, 6 Aagaard P, Di Biase L and Natale A (2015) Ablation of Atrial Arrhythmias in Heart Failure, Heart Failure Clinics, 10.1016/j.hfc.2014.12.008, 11:2, (305-317), Online publication date: 1-Apr-2015. Gasparovic H, Cikes M, Kopjar T, Hlupic L, Velagic V, Milicic D, Bijnens B, Colak Z and Biočina B (2014) Atrial apoptosis and fibrosis adversely affect atrial conduit, reservoir and contractile functions, Interactive CardioVascular and Thoracic Surgery, 10.1093/icvts/ivu095, 19:2, (223-230), Online publication date: 1-Aug-2014. Saltzman H (2014) Arrhythmias and Heart Failure, Cardiology Clinics, 10.1016/j.ccl.2013.09.005, 32:1, (125-133), Online publication date: 1-Feb-2014. Callans D and Anter E (2013) Nonpharmacologic Treatment of Tachyarrhythmias Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease, 10.1016/B978-1-4557-0101-8.00021-7, (383-395), . Mountantonakis S, Grau-Sepulveda M, Bhatt D, Hernandez A, Peterson E and Fonarow G (2012) Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart Failure, Circulation: Heart Failure, 5:2, (191-201), Online publication date: 1-Mar-2012. Riccioni G, Bucciarelli V, Di Ilio E, Scotti L, Aceto A, D'Orazio N, Martini F and Bucciarelli T (2011) Recurrent Atrial Fibrillation in a Patient with Ulcerative Colitis Treated with Azathioprine: Case Report and Review of the Literature, International Journal of Immunopathology and Pharmacology, 10.1177/039463201102400131, 24:1, (247-249), Online publication date: 1-Jan-2011. Schiller E, Maqsood M and Pagel P (2010) Cardiac Football or Cause of Severe Tricuspid Regurgitation?, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2009.10.004, 24:6, (1013-1015), Online publication date: 1-Dec-2010. Haruna T, Ikeguchi S, Takeda S, Amaya N, Hata T, Okada M and Kosuga K (2009) An Aggressive Strategy for Maintenance of Sinus Rhythm Including a Combination of Catheter Ablation and Antiarrhythmic Drug Therapy Benefits Patients with Chronic Atrial Fibrillation, Journal of Arrhythmia, 10.1016/S1880-4276(09)80018-5, 25:2, (63-69), . Zhang Q, Yip G and Yu C (2008) Approaching regional left atrial function by tissue Doppler velocity and strain imaging, Europace, 10.1093/europace/eun237, 10:Supplement 3, (iii62-iii69), Online publication date: 1-Nov-2008. PEREA R, TAMBORERO D, MONT L, De CARALT T, ORTIZ J, BERRUEZO A, MATIELLO M, SITGES M, VIDAL B, SANCHEZ M and BRUGADA J (2008) Left Atrial Contractility is Preserved After Successful Circumferential Pulmonary Vein Ablation in Patients with Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2007.01086.x, 19:4, (374-379), Online publication date: 1-Apr-2008. Zhang Q and Yu C (2008) Atrial Function Myocardial Imaging: Tissue Doppler and Speckle Tracking, 10.1002/9780470692448.ch21, (253-264) Quintana M, Lindell P, Saha S, del Furia F, Lind B, Govind S and Brodin L (2005) Assessment of atrial regional and global electromechanical function by tissue velocity echocardiography: a feasibility study on healthy individuals, Cardiovascular Ultrasound, 10.1186/1476-7120-3-4, 3:1, Online publication date: 1-Dec-2005. Naccarelli G (2016) Antiadrenergic Therapy in the Control of Atrial Fibrillation, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/10742484050100i405, 10:4_suppl, (S33-S43), Online publication date: 1-Oct-2005. Boodhoo L, Mitchell A, O'Connor J and Sulke N (2005) Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation, International Journal of Cardiology, 10.1016/j.ijcard.2004.08.028, 103:1, (67-72), Online publication date: 1-Aug-2005. Hettrick D, Schwartzman D, Tse H and Pagel P (2007) Mechanical Basis of Atrial Fibrillation Innovative Management of Atrial Fibrillation, 10.1002/9780470994818.ch3, (29-49) Psychari S, Apostolou T, Sinos L, Hamodraka E, Liakos G and Kremastinos D (2005) Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation, The American Journal of Cardiology, 10.1016/j.amjcard.2004.11.032, 95:6, (764-767), Online publication date: 1-Mar-2005. Kennedy H (2004) Use of Long-term (Holter) Electrocardiographic Recordings Cardiac Electrophysiology, 10.1016/B0-7216-0323-8/50087-7, (772-787), . Lombardi F, Tundo F, Colombo F, Belletti S and Tarricone D (2004) Sympathetic and Vagal Fibrillation: Do They Exist? Cardiac Arrhythmias 2003, 10.1007/978-88-470-2137-2_1, (1-10), . KALARUS Z, KOWALSKI O, LENARCZYK R, PROKOPCZUK J and PASYK S (2003) Electrophysiological Features of Orthodromic Atrioventricular Reentry Tachycardia in Patients with Wolff-Parkinson-White Syndrome and Atrial Fibrillation, Pacing and Clinical Electrophysiology, 10.1046/j.1460-9592.2003.t01-1-00214.x, 26:7p1, (1479-1488), Online publication date: 1-Jul-2003. Umana E, Solares C and Alpert M (2003) Tachycardia-induced cardiomyopathy, The American Journal of Medicine, 10.1016/S0002-9343(02)01472-9, 114:1, (51-55), Online publication date: 1-Jan-2003. Khan I (2002) Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter, American Heart Journal, 10.1067/mhj.2002.123113, 144:1, (11-22), Online publication date: 1-Jul-2002. Lombardi F, Colombo A, Basilico B, Ravaglia R, Garbin M, Vergani D, Battezzati P and Fiorentini C (2001) Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)01039-1, 37:1, (157-162), Online publication date: 1-Jan-2001. Almendral Garrote (coordinador) J, Marín Huerta E, Medina Moreno O, Peinado Peinado R, Pérez Álvarez L, Ruiz Granell R and Viñolas Prat X (2001) Guías de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas, Revista Española de Cardiología, 10.1016/S0300-8932(01)76313-0, 54:3, (307-367), Online publication date: 1-Jan-2001. Coll-Vinent Puig B, Sánchez Sánchez M and Mont Girbau L (2001) Nuevos conceptos en el tratamiento de la fibrilación auricular, Medicina Clínica, 10.1016/S0025-7753(01)72135-5, 117:11, (427-437), Online publication date: 1-Jan-2001. JAÏS P, PENG J, SHAH D, GARRFGUE S, HOCINI M, YAMANE T, HAISSAGUERRE M, BAROLD S, ROUDAUT R and CLEMENTY J (2000) Left Ventricular Diastolic Dysfunction in Patients with So-Called Lone Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2000.tb00023.x, 11:6, (623-625), Online publication date: 1-Jun-2000. BLACK I (2000) Spontaneous Echo Contrast: Where There's Smoke There's Fire, Echocardiography, 10.1111/j.1540-8175.2000.tb01153.x, 17:4, (373-382), Online publication date: 1-May-2000. KAMALESH M, COPELAND T and SAWADA S (2000) Effect of Inotropic Stimulation on Left Atrial Appendage Function in Atrial Myopathy of Chronic Atrial Fibrillation, Echocardiography, 10.1111/j.1540-8175.2000.tb01142.x, 17:4, (313-318), Online publication date: 1-May-2000. Pollick C (2000) Left Atrial Appendage Myopathy, Chest, 10.1378/chest.117.2.297, 117:2, (297-298), Online publication date: 1-Feb-2000. SAVELIEVA I and CAMM A (2000) Silent Atrial Fibrillation-Another Pandora's Box, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.2000.tb00794.x, 23:2, (145-148), Online publication date: 1-Feb-2000. HAÏSSAGUERRE M, JAÏS P, SHAH D, ARENTZ T, KALUSCHE D, TAKAHASHI A, GARRIGUE S, HOCINI M, PENG J and CLÉMENTY J (2000) Catheter Ablation of Chronic Atrial Fibrillation Targeting the Reinitiating Triggers, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2000.tb00727.x, 11:1, (2-10), Online publication date: 1-Jan-2000. Godoy C, Bassani R and Bassani J (1999) Role of Acetylcholine in Electrical Stimulation-Induced Arrhythmia in Rat Isolated Atria, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199910000-00001, 34:4, (475-479), Online publication date: 1-Oct-1999. HOBBS W, GELDER I, FITZPATRICK A, CRIJNS H and GARRATT C (1999) The Role of Atrial Electrical Remodeling in the Progression of Focal Atrial Ectopy to Persistent Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1999.tb00268.x, 10:6, (866-870), Online publication date: 1-Jun-1999. CHEVALIER P, OBADIA J, TIMOUR Q, BUI-XUAN B, FATEMI M, KIRKORIAN G, TABIB A, LOIRE R and TOUBOUL P (1999) Thoracoscopic Epicardial Radiofrequency Ablation for Vagal Atrial Fibrillation in Dogs, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1999.tb06811.x, 22:6, (880-886), Online publication date: 1-Jun-1999. ZIPES D (1999) An Overview of Arrhythmias and Antarrhythmic Approaches, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1999.tb00672.x, 10:2, (267-271), Online publication date: 1-Feb-1999. Sparks P, Jayaprakash S, Mond H, Vohra J, Grigg L and Kalman J (1999) Left atrial mechanical function after brief duration atrial fibrillation, Journal of the American College of Cardiology, 10.1016/S0735-1097(98)00585-3, 33:2, (342-349), Online publication date: 1-Feb-1999. Sparks P, Jayaprakash S, Vohra J, Mond H, Yapanis A, Grigg L and Kalman J (1998) Left atrial “stunning” following radiofrequency catheter ablation of chronic atrial flutter, Journal of the American College of Cardiology, 10.1016/S0735-1097(98)00253-8, 32:2, (468-475), Online publication date: 1-Aug-1998. Hoit B, Shao Y and Gabel M (1998) Left atrial systolic and diastolic function accompanying chronic rapid pacing-induced atrial failure, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.1998.275.1.H183, 275:1, (H183-H189), Online publication date: 1-Jul-1998. Lardo A, Halperin H, Yeung C, Jumrussirikul P, Atalar E and McVeigh E (1998) Magnetic resonance guided radiofrequency ablation: Creation and visualization of cardiac lesions Medical Image Computing and Computer-Assisted Intervention — MICCAI’98, 10.1007/BFb0056201, (189-196), . Franz M, Karasik P, Li C, Moubarak J and Chavez M (1997) Electrical Remodeling of the Human Atrium: Similar Effects in Patients With Chronic Atrial Fibrillation and Atrial Flutter, Journal of the American College of Cardiology, 10.1016/S0735-1097(97)00385-9, 30:7, (1785-1792), Online publication date: 1-Dec-1997. GALLAGHER M, OBEL O and CAMM A (1997) Tachycardia-Induced Atrial Myopathy:., Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1997.tb00631.x, 8:9, (1065-1074), Online publication date: 1-Sep-1997. Narayan S, Cain M and Smith J (1997) Atrial fibrillation, The Lancet, 10.1016/S0140-6736(97)06359-9, 350:9082, (943-950), Online publication date: 1-Sep-1997. Franz M (1997) Excitable Gap, Antiarrhythmic Actions, Electrical Remodeling: The Role Of MAP Recording in Atrial Fibrillation And Other Atrial Tachyarrhythmias Monophasic Action Potentials, 10.1007/978-3-642-60851-3_9, (126-138), . February 4, 1997Vol 95, Issue 3 Advertisement Article InformationMetrics Copyright © 1997 by American Heart Associationhttps://doi.org/10.1161/01.CIR.95.3.562 Originally publishedFebruary 4, 1997 KeywordsfibrillationatriumarrhythmiacardiomyopathyEditorials Advertisement